Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation

Stock Information for Revive Therapeutics Ltd

Loading

Please wait while we load your information from QuoteMedia.